Back to search

Article

From Hurdles to Breakthroughs: Building and Validating a PSMA-positive Triple-Negative Breast Cancer Mouse Model for Preclinical Targeted Radionuclide Therapy

2025-11-11

Abstract excerpt

<title>Abstract</title> <p> Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, for which targeted therapies are emerging. Prostate-specific membrane antigen (PSMA), expressed mainly by the endothelial cells of the neovascularization of TNBC, or tumor cells, is an interesting target in TNBC that needs to be studied. This study aims to validate a reproductible, PSMA-po...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12b3b268-b8b5-5b0a-a300-dd5129561306
DOI
10.21203/rs.3.rs-7904335/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
From Hurdles to Breakthroughs: Building and Validating a PSMA-positive Triple-Negative Breast Cancer Mouse Model for Preclinical Targeted Radionuclide TherapyDOI 10.21203/rs.3.rs-7904335/v1
Select a neighboring publication to make it the new centre.